Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session 3

3047 - Health-related quality of life in Greek haematogical malignancies patients undergoing chemotherapy


30 Sep 2019


Poster Display session 3


Maria Lavdaniti


Annals of Oncology (2019) 30 (suppl_5): v836-v845. 10.1093/annonc/mdz276


M. Lavdaniti1, S. Kosmaoglou2, A. Chatzinikolaou1, E. Zioga3, K. Marmara1, E. Stalika4, S. Zyga5, G. Tzavelas6

Author affiliations

  • 1 Nursing Department, Alexander Technological Educational Institute, 57400 - Thessaloniki/GR
  • 2 Statistics And Insurance Science, University of Piraeus, 18534 - Pireaus/GR
  • 3 Cardiologic Clinic, General Hospital of Veroia, 57400 - Veroia/GR
  • 4 Lab Of Medical Informatics, Aristotle University of Thessaloniki, 57400 - Thessaloniki/GR
  • 5 Nursing Department, University of Peloponessus, 37400 - Thessaloniki/GR
  • 6 Statistics And Insurance Science, University of Piraeus, 18534 - Piraeus/GR


Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 3047


Recent studies indicate that quality of life plays crucial role in cancer patients’ outcome. In order to obtain a more comprehensive view into this option, we applied three different questionnaires, the European Organization for Research and Treatment of Cancer Quality of Life Core 30 (EORTC QLQ-C30), the Functional Assessment of Cancer Therapy-general (FACT-G) and the generic Short –Form 36 (SF-36) for registering the haematological malignancies patients’ point of view.


A cross- sectional study was established involving 67 patients, treated in a large hospital in a major Northern Greek city, with haematological malignancies undergoing chemotherapy in cycle 3. Data was collected using the three aforementioned scales in addition with a questionnaire with demographic and clinical characteristics.


The vast majority of patients were men (n = 42, 62.7%) and married ( 65.7 %, n = 44). Ten out of sixty-seven were multiple myeloma patients (n = 10, 14.9%). The mean scores of overall scales were: SF-36: 47.93±18.84, FACT-G: 73.68±18.25, EORTC-QLQ: 70,70±17.93. Cronbach’s a was >0.70 for all of the subscales of the questionnaires. There is an exception in emotional well being subscale of FACT-G and in physical functional subscale of EORTC QLQ-C30. Also, there was a strong correlation (>0.50) between physical functional subscale and emotional function subscale of the FACT-G, EORTC QLQ-C30 and SF-36 instruments (p < 0.001) and generally between the overall scores of three questionnaires (r = 0.771, p < 0.001 between FACT-G, EORTC QLQ-C30; r = 0.771, p < 0.001 between SF-36 and FACT-G; r = 0.842 p < 0.001 between SF-36 and EORTC QLQ-C30).


The Greek versions of FACT-G, EORTC QLQ-C30 and SF-36 questionnaires are valuable tools that could be easily applied in a daily practical routine for assessing quality of life in patients with hematological malignancies. Additionally, the above procedure provides valid information to the nursing staff in order to help their patients to improve their quality of life having possible influence in the disease outcome.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.


Has not received any funding.


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.